PHASE II STUDY OF CARBOPLATIN (CBDCA) PLUS WEEKLY NAB-PACLITAXEL (NAB-PTX) IN ELDERLY PATIENTS (PTS) WITH NON-SMALL CELL LUNG CANCER (NSCLC): NORTH JAPAN L... Objectives This phase I/II study assessed the efficacy and safety of combination therapy with carboplatin (CBDCA) and nab-paclitaxel...